John Sullivan compensation by year
Mesa Laboratories Summary Compensation Table · all 3 fiscal years held| Component | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Salary | $373,976 | $412,637 | $2,000 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $361,636 | $255,300 | $82,000 |
| Non-equity incentive | $398,339 | $207,130 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $11,219 | $12,379 | $480 |
| Total | $1,145,170 | $887,446 | $594,480 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Mesa Laboratories Inc DEF 14A filed September 20, 2018, accession 0001437749-18-017231, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Mesa Laboratories Inc filed document, accession 0001437749-18-017231. Every figure is read from that document and cited to the page and table it appears in. Filed September 20, 2018.
Equity holdings
unvested awards at FY2018 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 8,573 | — | $89.70 |
| Option | 7,360 | — | $97.78 |
| Option | 10,716 | — | $70.56 |
| Option | 15,000 | — | $122.66 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Mesa Laboratories Inc's FY2018 proxy; value at the fiscal year-end close, as the company printed it.
Mesa Laboratories’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Gary Owens | CEO and President | $1,005,880 |
| John Sullivan · this page | Ph.D. (5) Chairman of the Board | $594,480 |
| John Sakys | Chief Financial Officer | $517,940 |
| Glenn Adriance | Former Chief Sales and Marketing Officer | $467,617 |
| Greg Dinoia | Senior Vice President of Commercial Operations | $374,204 |
Board service
Mesa Laboratories board · FY2021–FY2026| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2026 | $105,000 | $190,000 | — | $0 | $295,000 |
| FY2025 | $105,000 | $180,105 | — | $0 | $285,105 |
| FY2024 | $105,000 | $150,134 | — | $0 | $255,134 |
| FY2023 | $105,000 | $150,099 | — | $0 | $255,099 |
| FY2022 | $17,500 | $210,200 | — | $0 | $227,700 |
| FY2021 | $0 | $156,680 | — | $9,000 | $165,680 |
Each year as the company reported it in Mesa Laboratories's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: Mesa Laboratories pays directors a $60,000 cash retainer and $190,000 in RSUs. As stated in Mesa Laboratories's FY2026 proxy.
The full Mesa Laboratories compensation record
free company briefThis page is one person within Mesa Laboratories's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Mesa Laboratories proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Mesa Laboratories's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.